Updated from 4:02 p.m. EDTGenentech (DNA) is preparing to agree to a $95-per-share takeover by Roche, according to a report.

After months of haggling, Roche is closing in on a hostile bid to acquire biotech firm Genentech, according to The Wall Street Journal.

Friday, Roche raised its previous offer of $86.50 per share to $93 per share after persistent protests from Genentech that that price severely undercut its value. The move would give Roche, which has its eye on the cancer drug Avastin, the 44% of Genentech shares it doesn't already own.

According to the Journal, the two companies could announce a deal, which would amount to more than $46 billion in equity value, after the market closes Monday. It would be the second such announcment today, following Merck's ( MRK) $41.1 billion acquisition of Schering-Plough ( SGP).

Roche's original offer, in July, was $89 per share. Genentech posed a counteroffer of $112:

"Genentech's strong projected financial performance implies a valuation substantially in excess of Roche's offer price," said Charles Sanders, chairman of Genentech's special board committee, in a statement in February.

As TheStreet.com's Adam Feuerstein noted Monday, Big Pharma is primed for M&A activity -- witness the Merck-Schering-Plough deal as well as the deal between Pfizer ( PFE) and Wyeth ( WYE) earlier this year -- but Big Pharma-biotech matchups like the potential Genentech deal may be less likely to materialize than conventional wisdom dictates.

Genentech's stock closed Monday trading up 2% to $92.63.

More from Stocks

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Micron Shares Soar; Chipmaker Is 'Managing for Profitability' Now, Says Analyst

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Dow Slips 178 Points; S&P 500 and Nasdaq Also Decline

Facebook CEO Mark Zuckerberg Deflects Tough Questions From European Parliament

Facebook CEO Mark Zuckerberg Deflects Tough Questions From European Parliament

What Does China's Tariff Deal Mean for Automakers Like Tesla?

What Does China's Tariff Deal Mean for Automakers Like Tesla?

Lowe's Taps Home Depot Veteran As New CEO

Lowe's Taps Home Depot Veteran As New CEO